Egalet Corp (NASDAQ:EGLT)

0.44
Delayed Data
As of Jun 22
 -0.0052 / -1.17%
Today’s Change
0.42
Today|||52-Week Range
2.59
-56.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$32.0M

Company Description

Egalet Corp. engages in the development, manufacture, and commercialization of innovative treatments for pain and other conditions. The firm offers ARYMO, OXAYDO and SPRIX. Its products contain non-narcotic and abuse-deterrent opioid formulations. The company was founded by Jean-Francois B. Formela in August 2013 and is headquartered in Wayne, PA.

Contact Information

Egalet Corp.
600 Lee Road
Wayne Pennsylvania 19087
P:(610) 833-4200
Investor Relations:

Employees

Shareholders

Mutual fund holders4.50%
Other institutional18.83%
Individual stakeholders17.54%

Top Executives

Robert Samuel RadiePresident, Chief Executive Officer & Director
Mark StrobeckChief Operating Officer & Executive Vice President
Stanley J. MusialChief Financial Officer, Secretary & Executive VP
Karsten LindhardtChief Scientific Officer
Patrick Michael SheaChief Commercial Officer